<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>HIV co-infection &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/hiv-co-infection/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 09 Oct 2026 00:04:42 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>HIV co-infection &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Cameroon&#8217;s Drug-Resistant Tuberculosis Patients Fall Short of National Cure Targets, Major Review Finds</title>
		<link>https://bioengineer.org/cameroons-drug-resistant-tuberculosis-patients-fall-short-of-national-cure-targets-major-review-finds/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Fri, 09 Oct 2026 00:04:42 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[adverse drug events]]></category>
		<category><![CDATA[all-oral regimens]]></category>
		<category><![CDATA[Cameroon]]></category>
		<category><![CDATA[drug-resistant tuberculosis]]></category>
		<category><![CDATA[HIV co-infection]]></category>
		<category><![CDATA[Meta-analysis]]></category>
		<category><![CDATA[Mycobacterium tuberculosis]]></category>
		<category><![CDATA[ototoxicity]]></category>
		<category><![CDATA[Pharmacovigilance]]></category>
		<category><![CDATA[systematic review]]></category>
		<category><![CDATA[treatment outcomes]]></category>
		<category><![CDATA[treatment success rate]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=408859</guid>

					<description><![CDATA[A new systematic review of fifteen studies finds that only 74.2 percent of drug-resistant tuberculosis patients in Cameroon achieve treatment success, falling short of the national 85 percent target, with HIV co-infection, male sex, and high rates of adverse drug events identified as key concerns.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">408859</post-id>	</item>
	</channel>
</rss>
